MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    Face and color recognition after subthalamic nucleus stimulation in Parkinson’s disease

    A. Gündüz, S. Yagci, S. Aydin, B.Ç. Poyraz, G. Genç, S. Oguz, H. Apaydin, G. Kiziltan, H. Hanagasi, M. Hanci, S. Ertan (Istanbul, Turkey)

    Objective: We hypothesized that face recognition and color perception may also be impaired after STN DBS and we tested our hypothesis in a group of…
  • 2016 International Congress

    Cognitive impairment in patients with progressive supranuclear palsy and multiple system atrophy

    M. Vecerkova, M. Kaiserova, L. Hvizdosova, S. Kurcova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: Assessment, description and mutual comparison of cognitive impairment in patients with progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). Background: In most recent…
  • 2016 International Congress

    Parkinsonism risk factors in Salt Lake City, Utah

    D. Shprecher, K. Gannon, M. Halverson, R. Savica (Sun City, AZ, USA)

    Objective: To assess the prevalence of risk factors for parkinsonism in Salt Lake City (SLC), Utah. Background: Recent data suggest that non-motor symptoms including constipation,…
  • 2016 International Congress

    Protein levels of SV2A and VGLUT1 in brain tissue from patients with Parkinson’s disease, dementia with Lewy bodies and Alzheimer’s disease

    S. Frykman, M. Oosterhof, M.S. Ahmed, D. Howlet, T. Hortobagyi, P. Francis, D. Årsland (Huddinge, Sweden)

    Objective: The objective of this study was to investigate whether SV2A and/or VGLUT1 are suitable as markers for synaptic degeneration in neurodegenerative disorders and could…
  • 2016 International Congress

    Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up

    R.A. Lawson, A.J. Yarnall, G.W. Duncan, D.P. Breen, T.K. Khoo, C.H. Williams-Gray, R.A. Barker, D. Collerton, J.P. Taylor, D.J. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: To investigate the impact of cognition and cognitive decline on quality of life (QoL) in an incident Parkinson's disease (PD) cohort over three years.…
  • 2016 International Congress

    Heart rate variability to differentiate dementia with Lewy bodies from Alzheimer’s disease in patients with mild cognitive impairment

    J. Yoon, S.M. Lee, J.M. Hong (Suwon, Korea)

    Objective: We aimed to determine whether heart rate variability (HRV) can aid in the differentiation of DLB from AD at the MCI stage. Background: Mild…
  • 2016 International Congress

    Neuron specific protein S100B and cognitive impairment in various forms parkinsonism

    R.J. Matmurodov, K.M. Khalimova, N.S. Rashidova, U. Ergashev, O. Turgunhojayev (Tashkent, Uzbekistan)

    Objective: In Parkinson's disease (PD) in almost all patients at the early stages of developing cognitive impairment. Background: Study of the degree of cognitive impairment,…
  • 2016 International Congress

    The effects of deep brain stimulation for Parkinson’s disease on cognition and perceived quality of life: Preliminary results from an Ecuadorian sample

    M.B. Jurado Noboa, R. Santibañez Vásquez, J. Achi, M. Navarrete, C. Mawyin (Guayaquil, Ecuador)

    Objective: To evaluate the effects of deep brain stimulation (DBS) on cognition and perceived quality of life in the first cohort of patients undergoing DBS…
  • 2016 International Congress

    Sensitivity of people with Parkinson’s to different intensities of emotions (SPiEs)

    J. Wincenciak, D.J. Burn, L.S. Delicato (Newcastle upon Tyne, United Kingdom)

    Objective: To characterise the ability of individuals with Parkinson's to discriminate the six universal facial expressions. Background: People with Parkinson's (PwP) tend to have difficulty…
  • 2016 International Congress

    Effects of gender, age and hyposmia on cognitive functions in healthy elderly individuals at risk for Parkinson’s disease: Results from the TREND study

    S. Heinzel, U. Suenkel, F.G. Metzger, E. Schaeffer, B. Roeben, R. Yilmaz, S. Lerche, K. Brockmann, A.K. von Thaler, I. Liepelt-Scarfone, G.W. Eschweiler, A.J. Fallgatter, W. Maetzler, D. Berg (Tübingen, Germany)

    Objective: To evaluate the impact of gender, age and hyposmia on the cognitive performance in memory, language, executive, and visuo-spatial functions to set the stage…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley